KY Biotechnology & Medical Research

Belite Bio Inc (BLTE)

Track

Track

Belite Bio Inc experienced significant insider trading activity over the past ninety days, totaling twenty-six transactions. Executives, including the CEO and CFO, executed planned and proposed sales amounting to approximately 46.5 million dollars. These divestments occurred alongside the latest results financiers, while the stock price maintained a moderate upward trend during this period.
Ticker: BLTE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Belite Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
34.58
Quantity 14,478 +13.7%
Value US$3,800,430
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
287.72
Quantity 512 -18.4%
Value US$1,430,218
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
213.77
Quantity 23,685 +34.0%
Value US$3,362,084
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
180.00
Quantity 142 -0.1%
Value US$25,560
Yu-Hsin Lin CEO, Chairman
Transaction date
Proposed sale
Price
177.58
Quantity 126,800
Value US$22,517,144
Hao-Yuan Chuang Officer, Director Executive Director
Transaction date
Proposed sale
Price
177.58
Quantity 93,800
Value US$16,657,004
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
147.11
Quantity 96 -0.6%
Value US$14,123
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
147.11
Quantity 96 -0.6%
Value US$14,123
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
146.24
Quantity 1,199 -7.4%
Value US$175,348
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
146.24
Quantity 1,199 -7.4%
Value US$175,348
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.43
Quantity 4,861 -23.0%
Value US$706,959
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.43
Quantity 4,861 -23.0%
Value US$706,959
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
144.66
Quantity 3,748 -15.0%
Value US$542,192
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
144.66
Quantity 3,748 -15.0%
Value US$542,192
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.90
Quantity 96 -0.4%
Value US$13,814
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.90
Quantity 96 -0.4%
Value US$13,814
Dr. Hendrick P. Scholl Affiliate
Transaction date
Proposed sale
Price
148.34
Quantity 10,000
Value US$1,483,400
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.02
Quantity 1,035 -4.0%
Value US$150,097
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.55
Quantity 1,897 -6.8%
Value US$272,314
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
142.20
Quantity 450 -1.6%
Value US$63,988
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
141.83
Quantity 100 -0.4%
Value US$14,183
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
140.58
Quantity 540 -1.9%
Value US$75,915
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
139.57
Quantity 3,140 -9.8%
Value US$438,260
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
138.18
Quantity 784 -2.4%
Value US$108,331
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
137.61
Quantity 2,054 -5.9%
Value US$282,641
Dr. Hendrick P. Scholl Affiliate
Transaction date
Proposed sale
Price
144.24
Quantity 10,000
Value US$1,442,400
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.25
Quantity 9 -100.0%
Value US$1,397
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.61
Quantity 3 -25.0%
Value US$464
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
153.56
Quantity 428 -97.3%
Value US$65,725
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
152.45
Quantity 226 -33.9%
Value US$34,453
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.00
Quantity 100 -13.1%
Value US$15,600
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.97
Quantity 100 -11.5%
Value US$15,597
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.41
Quantity 240 -21.7%
Value US$37,059
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
153.42
Quantity 128 -10.4%
Value US$19,638
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
152.67
Quantity 424 -25.6%
Value US$64,733
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
151.57
Quantity 8 -0.5%
Value US$1,213
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
158.11
Quantity 68 -3.9%
Value US$10,751
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.29
Quantity 155 -8.2%
Value US$24,380
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.53
Quantity 121 -6.0%
Value US$18,940
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.48
Quantity 173 -7.9%
Value US$26,898
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.44
Quantity 363 -14.3%
Value US$56,063
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
153.92
Quantity 120 -4.5%
Value US$18,471
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.49
Quantity 172 -6.1%
Value US$27,088
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.57
Quantity 235 -7.6%
Value US$36,793
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.21
Quantity 325 -9.6%
Value US$50,442
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.24
Quantity 236 -6.5%
Value US$36,400
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
153.50
Quantity 32 -0.9%
Value US$4,912
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
160.00
Quantity 23 -0.6%
Value US$3,680
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
159.08
Quantity 38 -1.0%
Value US$6,045
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
158.35
Quantity 65 -1.7%
Value US$10,293
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.45
Quantity 106 -2.7%
Value US$16,690
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.24
Quantity 82 -2.1%
Value US$12,812
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.48
Quantity 346 -8.0%
Value US$53,795
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.38
Quantity 288 -6.2%
Value US$44,461
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
153.89
Quantity 52 -1.1%
Value US$8,002
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
158.15
Quantity 101 -2.1%
Value US$15,973
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.37
Quantity 340 -6.7%
Value US$53,506
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.59
Quantity 517 -9.2%
Value US$80,955
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.68
Quantity 42 -0.7%
Value US$6,538
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
158.19
Quantity 22 -0.4%
Value US$3,480
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.39
Quantity 102 -1.8%
Value US$16,053
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.43
Quantity 339 -5.5%
Value US$53,030
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.52
Quantity 259 -4.1%
Value US$40,280
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.58
Quantity 278 -4.2%
Value US$42,973
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
162.14
Quantity 54 -0.8%
Value US$8,756
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
161.72
Quantity 89 -1.3%
Value US$14,393
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
160.27
Quantity 120 -1.7%
Value US$19,233
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
159.42
Quantity 380 -5.2%
Value US$60,579
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
158.71
Quantity 62 -0.8%
Value US$9,840
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
157.49
Quantity 222 -2.9%
Value US$34,962
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.61
Quantity 53 -0.7%
Value US$8,300
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.36
Quantity 8 -0.1%
Value US$1,243
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.65
Quantity 12 -0.2%
Value US$1,856
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
164.07
Quantity 36 -0.5%
Value US$5,907
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
163.56
Quantity 409 -5.0%
Value US$66,895
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-12 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
14,478 +13.7%
34.58
US$3,800,430 		14,478 +13.7% 34.58 US$3,800,430
2026-08-14 2026-08-12 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
512 -18.4%
287.72
US$1,430,218 		512 -18.4% 287.72 US$1,430,218
2026-08-14 2026-08-12 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
23,685 +34.0%
213.77
US$3,362,084 		23,685 +34.0% 213.77 US$3,362,084
2026-08-14 2026-08-12 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
142 -0.1%
180.00
US$25,560 		142 -0.1% 180.00 US$25,560
2026-08-12 2026-08-12 PrS Proposed sale
Yu-Hsin Lin

CEO, Chairman
126,800
177.58
US$22,517,144 		126,800 177.58 US$22,517,144
2026-08-12 2026-08-12 PrS Proposed sale
Hao-Yuan Chuang

Officer, Director

Executive Director
93,800
177.58
US$16,657,004 		93,800 177.58 US$16,657,004
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.6%
147.11
US$14,123 		96 -0.6% 147.11 US$14,123
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.6%
147.11
US$14,123 		96 -0.6% 147.11 US$14,123
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,199 -7.4%
146.24
US$175,348 		1,199 -7.4% 146.24 US$175,348
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,199 -7.4%
146.24
US$175,348 		1,199 -7.4% 146.24 US$175,348
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-18 2026-06-18 PrS Proposed sale
Dr. Hendrick P. Scholl

Affiliate
10,000
148.34
US$1,483,400 		10,000 148.34 US$1,483,400
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,035 -4.0%
145.02
US$150,097 		1,035 -4.0% 145.02 US$150,097
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,897 -6.8%
143.55
US$272,314 		1,897 -6.8% 143.55 US$272,314
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
450 -1.6%
142.20
US$63,988 		450 -1.6% 142.20 US$63,988
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
100 -0.4%
141.83
US$14,183 		100 -0.4% 141.83 US$14,183
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
540 -1.9%
140.58
US$75,915 		540 -1.9% 140.58 US$75,915
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,140 -9.8%
139.57
US$438,260 		3,140 -9.8% 139.57 US$438,260
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
784 -2.4%
138.18
US$108,331 		784 -2.4% 138.18 US$108,331
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
2,054 -5.9%
137.61
US$282,641 		2,054 -5.9% 137.61 US$282,641
2026-06-16 2026-06-16 PrS Proposed sale
Dr. Hendrick P. Scholl

Affiliate
10,000
144.24
US$1,442,400 		10,000 144.24 US$1,442,400
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
9 -100.0%
155.25
US$1,397 		9 -100.0% 155.25 US$1,397
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
3 -25.0%
154.61
US$464 		3 -25.0% 154.61 US$464
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
428 -97.3%
153.56
US$65,725 		428 -97.3% 153.56 US$65,725
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
226 -33.9%
152.45
US$34,453 		226 -33.9% 152.45 US$34,453
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
100 -13.1%
156.00
US$15,600 		100 -13.1% 156.00 US$15,600
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
100 -11.5%
155.97
US$15,597 		100 -11.5% 155.97 US$15,597
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
240 -21.7%
154.41
US$37,059 		240 -21.7% 154.41 US$37,059
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
128 -10.4%
153.42
US$19,638 		128 -10.4% 153.42 US$19,638
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
424 -25.6%
152.67
US$64,733 		424 -25.6% 152.67 US$64,733
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
8 -0.5%
151.57
US$1,213 		8 -0.5% 151.57 US$1,213
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
68 -3.9%
158.11
US$10,751 		68 -3.9% 158.11 US$10,751
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
155 -8.2%
157.29
US$24,380 		155 -8.2% 157.29 US$24,380
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
121 -6.0%
156.53
US$18,940 		121 -6.0% 156.53 US$18,940
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
173 -7.9%
155.48
US$26,898 		173 -7.9% 155.48 US$26,898
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
363 -14.3%
154.44
US$56,063 		363 -14.3% 154.44 US$56,063
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
120 -4.5%
153.92
US$18,471 		120 -4.5% 153.92 US$18,471
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
172 -6.1%
157.49
US$27,088 		172 -6.1% 157.49 US$27,088
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
235 -7.6%
156.57
US$36,793 		235 -7.6% 156.57 US$36,793
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
325 -9.6%
155.21
US$50,442 		325 -9.6% 155.21 US$50,442
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
236 -6.5%
154.24
US$36,400 		236 -6.5% 154.24 US$36,400
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
32 -0.9%
153.50
US$4,912 		32 -0.9% 153.50 US$4,912
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
23 -0.6%
160.00
US$3,680 		23 -0.6% 160.00 US$3,680
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
38 -1.0%
159.08
US$6,045 		38 -1.0% 159.08 US$6,045
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
65 -1.7%
158.35
US$10,293 		65 -1.7% 158.35 US$10,293
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
106 -2.7%
157.45
US$16,690 		106 -2.7% 157.45 US$16,690
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
82 -2.1%
156.24
US$12,812 		82 -2.1% 156.24 US$12,812
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
346 -8.0%
155.48
US$53,795 		346 -8.0% 155.48 US$53,795
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
288 -6.2%
154.38
US$44,461 		288 -6.2% 154.38 US$44,461
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
52 -1.1%
153.89
US$8,002 		52 -1.1% 153.89 US$8,002
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
101 -2.1%
158.15
US$15,973 		101 -2.1% 158.15 US$15,973
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
340 -6.7%
157.37
US$53,506 		340 -6.7% 157.37 US$53,506
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
517 -9.2%
156.59
US$80,955 		517 -9.2% 156.59 US$80,955
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
42 -0.7%
155.68
US$6,538 		42 -0.7% 155.68 US$6,538
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
22 -0.4%
158.19
US$3,480 		22 -0.4% 158.19 US$3,480
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
102 -1.8%
157.39
US$16,053 		102 -1.8% 157.39 US$16,053
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
339 -5.5%
156.43
US$53,030 		339 -5.5% 156.43 US$53,030
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
259 -4.1%
155.52
US$40,280 		259 -4.1% 155.52 US$40,280
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
278 -4.2%
154.58
US$42,973 		278 -4.2% 154.58 US$42,973
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
54 -0.8%
162.14
US$8,756 		54 -0.8% 162.14 US$8,756
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
89 -1.3%
161.72
US$14,393 		89 -1.3% 161.72 US$14,393
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
120 -1.7%
160.27
US$19,233 		120 -1.7% 160.27 US$19,233
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
380 -5.2%
159.42
US$60,579 		380 -5.2% 159.42 US$60,579
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
62 -0.8%
158.71
US$9,840 		62 -0.8% 158.71 US$9,840
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
222 -2.9%
157.49
US$34,962 		222 -2.9% 157.49 US$34,962
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
53 -0.7%
156.61
US$8,300 		53 -0.7% 156.61 US$8,300
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
8 -0.1%
155.36
US$1,243 		8 -0.1% 155.36 US$1,243
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
12 -0.2%
154.65
US$1,856 		12 -0.2% 154.65 US$1,856
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
36 -0.5%
164.07
US$5,907 		36 -0.5% 164.07 US$5,907
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
409 -5.0%
163.56
US$66,895 		409 -5.0% 163.56 US$66,895
Explore more

More insider trading research around Belite Bio Inc

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity